Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-11-29-Speech-4-032"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-11-29"^^xsd:date2
dcterms:Is Part Of	lp_eu:Human genetics2
dcterms:Language	"el"^^xsd:language2
lpv:document identification number	"en.20011129.1.4-032"2
lpv:hasSubsequent	lp_eu:2001-11-29-Speech-4-0332
lpv:speaker	lp:Minerva Melpomeni Malliori2
lpv:spokenAs	member; Delegation to the EU-Russia Parliamentary Cooperation Committee (1999-10-06--2002-01-14)3 unknown; Panellinio Socialistiko Kinima (1999-07-20--2004-07-19)3 member; PES (1999-07-20--2004-07-19)3 substitute; Committee on Citizens' Freedoms and Rights, Justice and Home Affairs (2000-02-23--2002-01-14)3 member; Committee on the Environment, Public Health and Consumer Policy (1999-07-21--2002-01-14)3
lpv:translated text	"Mr President, when we decided, about a year ago, to set up the temporary parliamentary committee on human genetics and other new technologies in modern medicine, we did not for a minute imagine that the vote in question would coincide with statements by Heads of State, scientists, private companies and other interested parties. The announcement about advance cell technology, which uses cloning to create human embryos, makes today's vote even more crucial. The debates which have been held have brought minor differences to light in important sectors, such as the protection of human rights, the inviolability of human dignity, the right to self-determination, the confidentiality of personal data, respect for people with disabilities and the ban on discriminatory treatment of employees on the basis of genetic criteria. It was easy to reach a broad consensus on these issues. The Commission also agreed that genetic information on living human beings could not be patented. There was also almost unanimous agreement within the temporary committee on banning funding for research into reproductive cloning. However, it was on the sensitive issue of therapeutic cloning that the debate and differences of opinion took up most of our time. The lack of any international framework or regulations for applying this research and the risk of embryos being created in obscenely large or commercial numbers were behind some of the relatively strong reservations. Clearly, it will not be feasible to reach a broad consensus in this sector for the time being and the work of the temporary committee must continue so that a more detailed investigation can be carried out. I am positive that, if we can achieve international agreement and if private- and public-sector agencies operate in scientifically predetermined areas on the basis of agreed protocols, then the reservations which I mentioned will be put aside. This is the only way to resolve chronic health problems without running the risk of abuse which infringes the charter of human rights on human dignity, which are principles and values which must take precedence over freedom of research."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph